[1] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[2] |
LU Feichen, YOU Xuemei, ZHAO Fengjuan, LI Fanrong, WEI Shuangshuang, YANG Lijie.
Investigation on the status quo of the quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 468-473.
|
[3] |
WU Yan, JIANG Honghong, YANG Yongxiang, CHEN Jie.
Longitudinal association between symptom clusters and quality of life in perioperative rectal cancer patients: a network-based analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 474-480.
|
[4] |
XIAO Hui, QIN Hongen, YAO Ziyu, ZHOU Hui, MA Ronghe.
Paeoniflorin inhibiting the migration and invasion of endometrial cancer and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 623-630.
|
[5] |
GONG Jingjie, ZHANG Haibo, YANG Yi, CAO Jiayu, DING Nan, ZHAO Jun.
Influencing factors of quality of life in patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 322-327.
|
[6] |
WU Lili, ZHU Yingli, ZHUO Xiaolu, HUANG Lina, YE Dong.
Comparison of clinical efficacy of icotinib and gefitinib in the treatment of EGFR⁃mutated advanced lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 642-646.
|
[7] |
LUO Xixi, CHEN Jiamei, SHI Wei, CHEN Yongshun.
Efficacy and safety of Regorafenib combined with PD⁃1 inhibitors in advanced microsatellite stable colorectal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 521-528.
|
[8] |
CHEN Xiaolei, ZHANG Yong, ZHANG Yue, LI Jie, ZHOU Hebing .
Retrospective analysis of efficacy and prognosis of newly diagnosed multiple myeloma patients with 1q21 amplification
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 541-547.
|
[9] |
MENG Ni, ZHAO Bingbing, LONG Yaoxian, HE Shan, ZHANG Jieqing, LI Li.
Analysis of the effect of bone mesenchymal stem cells on endometrial cancer cells based on transcriptome sequencing
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(3): 281-287.
|
[10] |
QIU Liyan, YANG Li.
Application value of internet-based continuous management for nasopharyngeal carcinoma patients with symptoms 5 years after hospital discharge
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(3): 314-319.
|
[11] |
WANG Zimeng, XIANG Zuolin.
Clinical efficacy of stereotactic body radiation therapy on liver metastases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 641-646.
|
[12] |
PAN Zhaofang, ZHANG Xuan, FAN Jing.
Long-term life quality of acute leukemia patients after allogeneic hematopoietic stem cell transplantation and its influencing factors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 534-538.
|
[13] |
YANG Guangzhong, GENG Chuanying, WU Yin, LIU Aijun, LENG Yun, LI Yanchen, GAO Wen, CHEN Wenming.
Clinical efficacy of domestic bortezomib (Xintai) in the treatment of multiple myeloma and its safety
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(4): 385-388.
|
[14] |
LIU Bin, YANG Fang, LIN Xiang, YUAN Zhenchao.
Clinical efficacy of local microwave ablation combined with percutaneous kyphoplasty in the treatment of advanced acetabular metastases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 301-304.
|
[15] |
WEI Lingchun, LIAO Xiaoli, HUANG Wenfeng, LIAO Sina, LIU Zhihui, LI Yongqiang.
Association between HJURP gene polymorphism and the efficacy and adverse reactions of oxaliplatin-based chemotherapy for advanced hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 447-452.
|